EF
GSK icon

Empowered Funds’s GSK GSK Stock Holding History

Empowered Funds’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Sell
92,346
-1,158
-1% -$61.2K 0.03% 724
2026
Q1 		$5.16M Sell
93,504
-8,957
-9% -$485K 0.03% 621
2025
Q4 		$5.02M Buy
102,461
+16,936
+20% +$790K 0.09% 258
2025
Q3 		$3.69M Buy
85,525
+4,083
+5% +$159K 0.04% 605
2025
Q2 		$3.13M Buy
81,442
+2,268
+3% +$86.7K 0.04% 620
2025
Q1 		$3.07M Buy
79,174
+1,598
+2% +$58.5K 0.04% 541
2024
Q4 		$2.62M Buy
+77,576
New +$2.79M 0.04% 604

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Empowered Funds's GSK Position: Q2 2026 in Review

Empowered Funds reduced its GSK (GSK) stake by 1.2% in Q2 2026, selling an estimated $61.2K and leaving 92,346 shares worth $4.84M. The position accounts for 0.03% of the portfolio, ranked #724.

Empowered Funds first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.16M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Empowered Funds held 92,346 shares of GSK worth $4.84M as of Q2 2026.
  • Empowered Funds sold 1,158 GSK shares in Q2 2026, an estimated $61.2K.
  • GSK made up 0.03% of Empowered Funds's portfolio in Q2 2026, its #724 holding.
  • Empowered Funds first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Empowered Funds's GSK position peaked at $5.16M in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.